发明公开
EP1644342A1 GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO
有权
适合的性激素相关的病症,例如子宫内膜异位症,前列腺癌等的治疗芳基嘧啶
- 专利标题: GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO
- 专利标题(中): 适合的性激素相关的病症,例如子宫内膜异位症,前列腺癌等的治疗芳基嘧啶
-
申请号: EP04756667.4申请日: 2004-07-06
-
公开(公告)号: EP1644342A1公开(公告)日: 2006-04-12
- 发明人: HUANG, Charles, Q. , CHEN, Chen , CHEN, Yongsheng , GUO, Zhiqiang , WADE, Warren , ROWBOTTOM, Martin , RUETER, Jaimie, K.
- 申请人: NEUROCRINE BIOSCIENCES, INC.
- 申请人地址: 12790 El Camino Real San Diego, CA 92130-1102 US
- 专利权人: NEUROCRINE BIOSCIENCES, INC.
- 当前专利权人: NEUROCRINE BIOSCIENCES, INC.
- 当前专利权人地址: 12790 El Camino Real San Diego, CA 92130-1102 US
- 代理机构: Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
- 优先权: US485424P 20030707
- 国际公布: WO2005007633 20050127
- 主分类号: C07D239/54
- IPC分类号: C07D239/54 ; C07D403/12 ; A61K31/513 ; A61P5/06 ; C07D241/00 ; C07D239/00 ; C07D207/00
摘要:
GnRH receptor antagonists are disclosed that have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein n, R1a, R1b, R1c, R2a, R2b, R3, R4, R5, R6 and X are as defined herein, including stereoisomers, prodrugs and pharmaceutically acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
公开/授权文献
信息查询